164 related articles for article (PubMed ID: 31386874)
1. Carboxymethyl cellulose is a superior polyanion to dextran sulfate in stabilizing and enhancing the solubility of amorphous drug-polyelectrolyte nanoparticle complex.
Dong B; Hadinoto K
Int J Biol Macromol; 2019 Oct; 139():500-508. PubMed ID: 31386874
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP.
Dong B; Lim LM; Hadinoto K
Eur J Pharm Sci; 2019 Oct; 138():105035. PubMed ID: 31386892
[TBL] [Abstract][Full Text] [Related]
3. Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine.
Dong B; Hadinoto K
Drug Dev Ind Pharm; 2017 Jun; 43(6):996-1002. PubMed ID: 28121189
[TBL] [Abstract][Full Text] [Related]
4. Ternary nanoparticle complex of antibiotic, polyelectrolyte, and mucolytic enzyme as a potential antibiotic delivery system in bronchiectasis therapy.
Tran TT; Hadinoto K
Colloids Surf B Biointerfaces; 2020 Sep; 193():111095. PubMed ID: 32416520
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the stability of amorphous drug-polyelectrolyte nanoparticle complex using a secondary small-molecule drug as the stabilizer: A case study of ibuprofen-stabilized curcumin-chitosan nanoplex.
Lim LM; Hadinoto K
Int J Pharm; 2020 Feb; 575():119007. PubMed ID: 31893545
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility.
Cheow WS; Hadinoto K
J Colloid Interface Sci; 2012 Feb; 367(1):518-26. PubMed ID: 22051687
[TBL] [Abstract][Full Text] [Related]
7. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
8. Proof-of-concept preparation and characterization of dual-drug amorphous nanoparticle complex as fixed-dose combination of poorly soluble drugs.
Yu H; Ming Lim L; Dong B; Hadinoto K
Drug Dev Ind Pharm; 2019 Jan; 45(1):105-116. PubMed ID: 30196726
[TBL] [Abstract][Full Text] [Related]
9. Impacts of dextran sulfate's chain length on the characteristics of its self-assembled colloidal complex formed with amphiphilic small-molecule drug.
Yu H; Hadinoto K
Int J Biol Macromol; 2017 Oct; 103():493-500. PubMed ID: 28528943
[TBL] [Abstract][Full Text] [Related]
10. Amorphous nanodrugs prepared by complexation with polysaccharides: carrageenan versus dextran sulfate.
Cheow WS; Kiew TY; Hadinoto K
Carbohydr Polym; 2015 Mar; 117():549-558. PubMed ID: 25498670
[TBL] [Abstract][Full Text] [Related]
11. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison between millifluidic and bulk-mixing platform in the synthesis of amorphous drug-polysaccharide nanoparticle complex.
Dong B; Hadinoto K
Int J Pharm; 2017 May; 523(1):42-51. PubMed ID: 28323097
[TBL] [Abstract][Full Text] [Related]
13. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan.
Nguyen MH; Yu H; Dong B; Hadinoto K
Eur J Pharm Sci; 2016 Jun; 89():163-71. PubMed ID: 27140843
[TBL] [Abstract][Full Text] [Related]
14. Green preparation of antibiotic nanoparticle complex as potential anti-biofilm therapeutics via self-assembly amphiphile-polyelectrolyte complexation with dextran sulfate.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2012 Apr; 92():55-63. PubMed ID: 22154010
[TBL] [Abstract][Full Text] [Related]
15. Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug-Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug.
Lim LM; Park JW; Hadinoto K
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631565
[TBL] [Abstract][Full Text] [Related]
16. Green amorphous nanoplex as a new supersaturating drug delivery system.
Cheow WS; Hadinoto K
Langmuir; 2012 Apr; 28(15):6265-75. PubMed ID: 22439687
[TBL] [Abstract][Full Text] [Related]
17. A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin.
Yu H; Nguyen MH; Cheow WS; Hadinoto K
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():25-33. PubMed ID: 28415461
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluating the presumed superiority of amorphous nanoparticles over amorphous microscale solid dispersion in solubility enhancement of poorly soluble drugs.
Lim LM; Tran TT; Cheow WS; Hadinoto K
Eur J Pharm Sci; 2017 Nov; 109():455-463. PubMed ID: 28889027
[TBL] [Abstract][Full Text] [Related]
19. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
20. Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin-chitosan nanoparticle complex.
Yu H; Nguyen MH; Hadinoto K
Drug Dev Ind Pharm; 2018 Jan; 44(1):82-88. PubMed ID: 28849675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
